Moderna testing new COVID-19 vaccine as potential booster shot
- The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
- Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.